Skip to content

PHARMACEUTICO ANALYTICAL STUDY AND CLINICAL EVALUATION OF MESALOCANADI CURNA IN DADRU KUSTHA OPEN PARENTHESIS TINEA CORPORIS CLOSE PARENTHESIS

PHARMACEUTICO-ANALYTICAL STUDY AND CLINICAL EVALUATION OF MESALOCANADI CURNA IN DADRU KUSTHA OPEN PARENTHESIS TINEACORPORIS CLOSE PARENTHESIS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099697
Enrollment
60
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Sri Venkateshwara Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical signs and symptoms of Dadru Kushta viz., Kandu, Raga, Utsanna mandala and Pidaka. Patients of 18-60 years of either gender.

Exclusion criteria

Exclusion criteria: Secondary infections, malignancy, diabetes mellitus, Immune compromised and HIV patients. Patients having skin diseases other than Dadru and other bacterial infections like SLE, cellulitis, psoriasis and viral skin infections like herpes zoster, warts and chicken pox.

Design outcomes

Primary

MeasureTime frame
To compare the efficacies of mesalocanadi curna in group A and chakramarda beeja churna in group B in the management of dadruTimepoint: Group A-At baseline after completion of treatment at 7th,14th,21st and 28th day. Group B-At baseline after completion of treatment 7th,14th,21st,28th day.

Secondary

MeasureTime frame
To compare the efficacies of mesalocanadi curna in group A and chakramarda beeja curna as a lepa in group B in the management of dadru and assessment of recurrence after treatment.Timepoint: Group A-At baseline after completion of treatment at 7th,14th,21st and 28th day. Group B-At baseline after completion of treatment 7th,14th,21st,28th day.

Countries

India

Contacts

Public ContactDr Ch Sridurga

Sri Venkateswara Ayurvedic college and hospital

pennerudurga@gmail.com8919423127

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026